Compare OSBC & OPK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | OSBC | OPK |
|---|---|---|
| Founded | 1981 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 921.2M |
| IPO Year | 2014 | 2011 |
| Metric | OSBC | OPK |
|---|---|---|
| Price | $19.92 | $1.22 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 4 | 5 |
| Target Price | ★ $22.63 | $2.03 |
| AVG Volume (30 Days) | 282.5K | ★ 2.3M |
| Earning Date | 04-21-2026 | 05-29-2026 |
| Dividend Yield | ★ 1.41% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 1.62 | N/A |
| Revenue | N/A | ★ $606,879,000.00 |
| Revenue This Year | $25.15 | N/A |
| Revenue Next Year | $3.21 | $8.75 |
| P/E Ratio | $12.31 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $14.21 | $1.11 |
| 52 Week High | $22.00 | $2.04 |
| Indicator | OSBC | OPK |
|---|---|---|
| Relative Strength Index (RSI) | 45.91 | 46.64 |
| Support Level | $19.30 | $1.12 |
| Resistance Level | $21.33 | $1.27 |
| Average True Range (ATR) | 0.61 | 0.04 |
| MACD | -0.09 | 0.01 |
| Stochastic Oscillator | 36.68 | 60.71 |
Old Second Bancorp Inc is a bank holding company. It provides consumer and commercial banking products such as demand, money market, savings, time deposit, and individual retirement as well as commercial, industrial, consumer, and real estate lending, including installment loans, student loans, agricultural loans, lines of credit and overdraft checking, safe deposit operations, trust services, wealth management services, and additional services tailored to the needs of individual customers, corporates, small-medium enterprises. The Company has one operating segment, which is community banking. The company's revenue consists of interest, commission, payments, and other income.
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics. The Pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. The Diagnostics segment consists of clinical and genomics laboratory operations through BioReference and point-of-care operations. It generates the majority of its revenue from the Diagnostics segment.